This episode was recorded in person at the JP Morgan Healthcare Conference in San Francisco. Biotech history buffs will especially enjoy the first half, where he talks about what pharmaceutical sales was like and what it was like to work at Amgen in the early days.

// October 12, 2022 | Biotech 2050 Podcast

A New Vision for Cell and Gene Therapy, Andrew Sandford & Michael Paglia, ElevateBio BaseCamp

Andrew Sandford and Michael Paglia are the President and COO, respectively, of ElevateBio BaseCamp, a cell and gene therapy technology company powering transformative therapies. They join us from the company’s manufacturing facilities in Waltham, Massachusetts, for a discussion about the landscape of company creation in the cell and gene therapy space and how ElevateBio is helping companies bring innovation and therapeutics to clinics and patients to help treat and cure diseases.

// July 12, 2022 | Ori Spotlight

Events & Publications

Events

Cell & Gene Meeting on the Mesa

Advanced Therapies Week

Posters & Presentations

Optimization of Nuclease Treatment for Removal of Residual DNAs in Adeno-Associated Viruses

Development of a Proprietary HEK293 Suspension Cell Line for Robust rAAV and LVV Production

Utilizing PAM diversity for allele-specific knockdown of mut-HTT in vivo

Development and Optimization of a Scalable Affinity Purification of Adeno Associated Virus Serotype 6

Allele-selective SNP editing utilizing AAV5-delivered Life Edit® nuclease and guide RNA resulting in meaningful reduction of mutant HTT protein

Mutant and wildtype huntingtin protein quantitation utilizing automated capillary electrophoresis

Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein

A Scalable and Robust Lentiviral Platform for GMP Manufacturing

Compact RNA-guided nucleases from nonpathogenic soil microbes provide new tools for efficient and robust editing in human cells

A Robust and Scalable Platform Process for GMP Manufacturing of Lentiviral Vectors

Publications

A Life in Biotech & the Cell Therapy Wave: David Hallal on The Long Run